Candida Skull Base Osteomyelitis: a Case Report and Literature Review
Language English Country Czech Republic Media print
Document type Case Reports, Journal Article, Review
PubMed
32771074
DOI
10.14712/18059694.2020.22
PII: am_2020063020082
Knihovny.cz E-resources
- Keywords
- candida, fungal, osteomyelitis, otitis externa, skull base,
- MeSH
- Anti-Bacterial Agents therapeutic use MeSH
- Antifungal Agents therapeutic use MeSH
- Skull Base MeSH
- Fluconazole therapeutic use MeSH
- Candidiasis complications MeSH
- Diabetes Complications complications MeSH
- Middle Aged MeSH
- Humans MeSH
- Osteomyelitis drug therapy microbiology MeSH
- Otitis Externa drug therapy microbiology MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Review MeSH
- Names of Substances
- Anti-Bacterial Agents MeSH
- Antifungal Agents MeSH
- Fluconazole MeSH
Skull base osteomyelitis (SBO) also commonly known as malignant otitis externa was first described by Meltzer and Kelemen in 1959. Prior to the advent of the antibiotic era, this disease carried a poor prognosis with significant morbidity. It often proved fatal with mortality rates as high as 50%. Commonly seen in the immunocompromised patients, diabetes mellitus is an important associated comorbidity in the pathophysiologic development of this disease. Treatment is instituted by medical therapy with surgery having a limited role. Surgical intervention has a limited role, for example, in fungal SBO. Such cases may require local debridement and intraoperative tissue biopsies for histopathologic confirmation. This is to demonstrate fungal invasion into the skull base, as well as to exclude other sinister differential diagnoses like squamous cell carcinoma of temporal bone. In this case report, we present a rare case of candida SBO and the literature review.
References provided by Crossref.org